Systemic lupus erythematosus (SLE) mortality has decreased significantly in Japan over 40 years, mainly due to improved treatments and reduced renal failure deaths. Advances in therapies and infection control have enhanced patient prognosis and survival rates.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Discussion:
Key Insights:
Outlook: